Moreover, in patients with end stage renal disease on hemodialysis, circulating S100A12 levels are associated with cardiovascular mortality (38, 39), progression of abdominal aortic calcification (40) and with progression of CAC (41). Here, S100A12 is linked to chronic kidney disease.